Shobhaben Pratapbhai Patel- School of Pharmacy and Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai 400056, Maharashtra, India.
Shobhaben Pratapbhai Patel- School of Pharmacy and Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai 400056, Maharashtra, India.
Int J Pharm. 2021 May 15;601:120590. doi: 10.1016/j.ijpharm.2021.120590. Epub 2021 Apr 23.
Anemia poses a threat to a broad population globally as depleted hemoglobin leads to a plethora of conditions, and the most common cause includes iron deficiency. Iron is an essential element important for erythropoiesis, DNA synthesis, protection of the immune system, energy production, and cognitive function and hence should be maintained at appropriate levels. Various proteins are involved in transporting and absorption of iron, activation of heme synthesis, and RBC production that could be possible targets to improve iron delivery. Oral supplementation of iron either from dietary or synthetic sources has been the frontline therapy for treating iron deficiency in anemia. At the same time, intravenous administration is provided in chronic anemia, such as chronic kidney diseases (CKD). This review focuses on the strategies developed to overcome the disadvantages of available iron therapies and increase iron absorption and uptake in the body to restore iron content. Nanotechnology combined with the food fortification processes gained attention as they help develop new delivery systems to improve iron uptake by enterocytes. Furthermore, naturally obtained products such as polysaccharides, peptides, proteins, and new synthetic molecules have been used in fabrication of iron-carrier systems. The establishment of transdermal iron delivery systems such as microneedle arrays or iontophoresis, or the discovery of new molecules also proved to be an effective way for delivering iron in patients non-compliant to oral therapy.
贫血症在全球范围内对广大人群构成威胁,因为血红蛋白的减少会导致多种疾病,而最常见的原因包括缺铁。铁是一种对于红细胞生成、DNA 合成、免疫系统保护、能量产生和认知功能至关重要的必需元素,因此应保持在适当的水平。多种蛋白质参与铁的运输和吸收、血红素合成的激活以及红细胞的生成,这些都可能成为改善铁输送的潜在靶点。口服补充铁剂,无论是来自饮食还是合成来源,一直是治疗贫血症缺铁的一线疗法。同时,在慢性贫血症(如慢性肾脏病,CKD)中也会提供静脉内给药。本综述重点关注开发克服现有铁疗法缺点的策略,以及增加体内铁的吸收和摄取以恢复铁含量。纳米技术与食品强化过程相结合,引起了人们的关注,因为它们有助于开发新的输送系统,以提高肠细胞对铁的吸收。此外,天然存在的产品,如多糖、肽、蛋白质和新的合成分子,已被用于制造铁载体系统。建立经皮铁输送系统,如微针阵列或离子电渗,或发现新的分子,也被证明是一种在不遵守口服治疗的患者中输送铁的有效方法。